Hirsutism medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:


==Medical Therapy==
==Medical Therapy==
Cosmetic therapy : Bleaching , shaving , depilating agents ,waxing treatments , Eflornithine hydrochloride cream (Vaniqa)
===Pharmacologic Treatment===
 
====Hormonal Therapy====
Hormonal Therapy :
* [[Oral contraceptives]] : Suppresses free [[testosterone]] level eg Yasmin which contains 30 microgram of [[estradiol]] and 3mg of drospirenone or Yaz (20microgram of estradiol and 3mg of drospirenone).
* [[Oral contraceptives]] : Suppresses free [[testosterone]] level
* [[Gonadotropin-releasing hormone agonist]]<nowiki/>s :An  alternative to [[oral contraceptives]]<ref name="Rosenfield2005">{{cite journal|last1=Rosenfield|first1=Robert L.|title=Hirsutism|journal=New England Journal of Medicine|volume=353|issue=24|year=2005|pages=2578–2588|issn=0028-4793|doi=10.1056/NEJMcp033496}}</ref>
 
If a [[tumor]] of [[ovaries]] or [[adrenal gland]]<nowiki/>s is the underlying cause of hirsutism, surgery may be the treatment option.
* [[Glucocorticoid]] : In patients with [[CAH]]
* Parenteral long acting gonadotropin-releasing hormone analogues combined with OCPs containing estrogen and progestin for severe hirsutism not respinding to OCPs and antiandrogen e.g Leuprolide.


* 5α-reductase inhibitor : Finestride
====Adrenal Suppression====
* Oral [[glucocorticoids]] : In patients with [[CAH]] eg Prednisone or Dexamethasone.
* Metformin for infertile women with [[PCOS]].


* [[Gonadotropin-releasing hormone agonist]]<nowiki/>s :An  alternative to [[oral contraceptives]]<ref name="Rosenfield2005">{{cite journal|last1=Rosenfield|first1=Robert L.|title=Hirsutism|journal=New England Journal of Medicine|volume=353|issue=24|year=2005|pages=2578–2588|issn=0028-4793|doi=10.1056/NEJMcp033496}}</ref>
====Antiandrogens====
If a [[tumor]] of [[ovaries]] or [[adrenal gland]]<nowiki/>s is the underlying cause of hirsutism, surgery may be the treatment option.
* Finestride: A 5α-reductase inhibitor, 2.5mg daily. (this is rarely used because it causes fatal hepatitis with a high risk of being teratogenic.
* Eflornithine hydrochloride cream (Vaniqa): Applied twice daily to the face.  


[[Laser therapy]] can remove unwanted hair for some women specially for women with dark hair and light skin.<ref name="Franks2012">{{cite journal|last1=Franks|first1=Stephen|title=The investigation and management of hirsutism|journal=Journal of Family Planning and Reproductive Health Care|volume=38|issue=3|year=2012|pages=182–186|issn=1471-1893|doi=10.1136/jfprhc-2011-100175}}</ref>
===Non-Pharmacologic Treatment===
* Cosmetic therapy : Bleaching, shaving, depilating agents, plucking, waxing treatments.
* Electrosurgical methods include electrosurgical epilation and [[Laser therapy]] which can remove unwanted hair for some women specially for women with dark hair and light skin.<ref name="Franks2012">{{cite journal|last1=Franks|first1=Stephen|title=The investigation and management of hirsutism|journal=Journal of Family Planning and Reproductive Health Care|volume=38|issue=3|year=2012|pages=182–186|issn=1471-1893|doi=10.1136/jfprhc-2011-100175}}</ref>


==References==
==References==

Revision as of 16:55, 22 September 2017

Hirsutism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hirsutism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasonography

Treatment

Medical Therapy

Pharmacological therapy
Non-pharmacological therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hirsutism medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hirsutism medical therapy

CDC on Hirsutism medical therapy

Hirsutism medical therapy in the news

Blogs on Hirsutism medical therapy

Directions to Hospitals Treating Hirsutism medical therapy

Risk calculators and risk factors for Hirsutism medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: ; Ogheneochuko Ajari, MB.BS, MS [2] Rasam Hajiannasab M.D.[3]

Overview

Many women with unwanted hair seek methods of hair removal to control the appearance of hirsutism. But the actual causes should be evaluated by physicians, who can conduct blood tests, pinpoint the specific origin of the abnormal hair growth, and advise on the best course of treatment.

Medical Therapy

Pharmacologic Treatment

Hormonal Therapy

If a tumor of ovaries or adrenal glands is the underlying cause of hirsutism, surgery may be the treatment option.

  • Parenteral long acting gonadotropin-releasing hormone analogues combined with OCPs containing estrogen and progestin for severe hirsutism not respinding to OCPs and antiandrogen e.g Leuprolide.

Adrenal Suppression

  • Oral glucocorticoids : In patients with CAH eg Prednisone or Dexamethasone.
  • Metformin for infertile women with PCOS.

Antiandrogens

  • Finestride: A 5α-reductase inhibitor, 2.5mg daily. (this is rarely used because it causes fatal hepatitis with a high risk of being teratogenic.
  • Eflornithine hydrochloride cream (Vaniqa): Applied twice daily to the face.

Non-Pharmacologic Treatment

  • Cosmetic therapy : Bleaching, shaving, depilating agents, plucking, waxing treatments.
  • Electrosurgical methods include electrosurgical epilation and Laser therapy which can remove unwanted hair for some women specially for women with dark hair and light skin.[2]

References

  1. Rosenfield, Robert L. (2005). "Hirsutism". New England Journal of Medicine. 353 (24): 2578–2588. doi:10.1056/NEJMcp033496. ISSN 0028-4793.
  2. Franks, Stephen (2012). "The investigation and management of hirsutism". Journal of Family Planning and Reproductive Health Care. 38 (3): 182–186. doi:10.1136/jfprhc-2011-100175. ISSN 1471-1893.

Template:WH Template:WS